After shutting down a Johns Hopkins-run trial that likely saved thousands of lives, the Department of Health and Human Services moved to reassure both hospitals and researchers that they won?t face unnecessary red tape when trying to improve patient safety.
“We do not want to stand in the way of quality improvement activities that pose minimal risks to subjects,” said Dr. Ivor Pritchard, acting director of Office for Human Research Protections.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.